HOME QUICK SEARCH AUTHORS KEYWORDS HELP BUGS

pk parameter

76 papers and 3 presentations; 79 titles.

Back to keywords

Conference × Year × Title × Authors Extras Pages
PharmaSUG CN 2026 A Comprehensive R Shiny Application for Pharmacokinetic Analysis Keyi Zhang source 17
PharmaSUG 2026 An End-to-End R-Based Pharmacokinetics (PK) Workflow for Regulatory Submission: The INAVO120 Study Qi Liu,
Shweta Vadhavkar		 source 5
PharmaSUG 2026 Enhancing ADaM PK Datasets to Automate PK TFLs Generation Jianli Ping,
Karthik Sankepelli		 source 12
PharmaSUG 2026 Oncology Solid Tumor Subcutaneous vs Intravenous Late-stage Study Analysis Sumanjali Mangalarapu,
Chuqing Chen,
Anilkumar Anksapur		 source 11
PharmaSUG 2026 Two Paths, One PK Journey: The Art of Balancing ADPC and ADNCA Ashok Abburi,
Rakhe Jacob,
Shibani Harite		 source 7
PHUSE US 2026 Pharmacokinetic Noncompartmental Analysis (PK NCA) Using R: An Efficient Cost-Effective Alternative to Industry-Standard Software Jennifer Menda,
Haley Evans		 source
poster source		 5
PHUSE EU 2025 Pharmacokinetics Is Simple... Sometimes Vincent Buchheit source
presentation source		 12
PharmaSUG 2025 A discussion of the new ADaM guidance (ADNCA and ADPPK) for pharmacokinetics. Luke Reinbolt source 3
PharmaSUG 2025 AI-Assisted Transition: from SAS to RStudio for PK Summary Analysis Shiqi Lin source 9
PharmaSUG 2025 What comes first, the chicken (ADSL) or the egg (ADNCA)? Modularize your covariate creation to support flexible analysis dataset implementation! David C. Izard source 6
PHUSE US 2025 Role of PK/PD, Biomarker Analysis in the Expansion of Phase 1 Trials Lavanya Peddibhotla source
presentation source		 7
PHUSE EU 2024 Introduction to the ADNCA ADaM Charlotte Hampson,
Florence Horspole		 source
poster source		 4
PharmaSUG 2024 Game changer! The new CDISC ADaM domain ADNCA for PK/PD data analysis Santosh Ranjan source 7
PHUSE US 2024 Unveiling the Potential of ADNCA via the CDISC ADaM IG: Revolutionising Pharmacokinetic Non-Compartmental Analysis Input Data Standardisation Saumilkumar Tripathi source
presentation source		 10
PharmaSUG 2023 'TUFF' LOVE: SDTM Pain Points Explained! Kristin Kelly,
Michael Beers		 source 12
PharmaSUG 2023 SAS-based Method for PK Noncompartmental Analysis and Validation Hui Mao,
Lixin Gao		 source 5
PharmaSUG 2022 Merging Pharmacokinetic (PK) Sample Collection and Dosing Information for PK Analysis based on Study Design and lessons learned Durga Kalyani Paturi source 11
PharmaSUG 2022 Pharmacokinetics Concentration Data Deciphered - Presenting an Oncology Case Study Nikita Sathish source 9
PharmaSUG 2022 Standardizing Procedures for Generating Dose Proportionality Figures to Improve Programming Efficiency Jianli Ping,
Krishna Sivakumar		 source 11
PharmaSUG 2022 Unravel the mystery around NONMEM data sets for statistical programmers Sabarinath Sundaram,
Lyma Faroz		 source 9
PHUSE EU 2021 Preparing PK/PD ADaM Datasets and eCRT Data Package for FDA Submission Junying Zhang source
video
presentation source		 11
PHUSE EU 2020 Guide to Electronic Submission of Pharmacometric Datasets and Analyses to the Regulatory Authorities [presentation] Pooja Kulkarni source
video		 17
PHUSE EU 2020 Population Pharmacokinetic Model in SAS - Application with proc MCMC [presentation] Bruno Boulanger,
Maud Hennion		 source
video		 25
SGF 2020 Transdermal Medicine - Challenges and Solutions with SAS Marina Komaroff source 14
PharmaSUG 2020 Enhanced Visualization of Clinical Pharmacokinetics Analysis by SAS GTL Min Xia source 9
PHUSE EU 2019 Bioequivalence Testing for Highly Variable Drug Products (HVDPs) James R. Johnson source
presentation source		 9
PHUSE EU 2019 Pharmacokinetic and Statistical Considerations in First-in-Human Clinical Trials Joanna Magielse source
presentation source		 4
PHUSE EU 2019 Programming in the World of PK: Guidance for the Beginner Paige Lewis source
poster source		 7
PharmaSUG 2019 ADME Study PK SDTM/ADaM And Graph Fan Lin source 9
PharmaSUG 2019 Considerations in Effectively Generating PK Analysis Input Datasets Jianli Ping source 10
PharmaSUG 2019 Pharmacokinetic Parameters for Sparse and Intensive Sampling - Nonclinical and Clinical Studies Shallabh Mehta source 5
PHUSE US 2019 Graphical Examination of PK Parameters Versus Dose-in-Dose Escalation Trials using SAS GTL Chiu Tsang,
Hima Bhatia		 source
poster source		 9
PHUSE EU 2018 An Efficient Way for Statistical Review Using RShiny Application Adarsh Nagare,
Sameer Bamnote		 source
presentation source		 9
PHUSE EU 2018 Lessons Learned for Successful e-Study Data Submission to the PMDA towards the End of the Transitional Period Takashi Kitahara,
Ayako Noda		 source
presentation source		 12
PHUSE US 2018 Making PK Analysis Easier: The New ADaM Data Standard ADNCA Peter Schaefer source
presentation source		 6
PHUSE US 2018 Methods for Handling Concentration Values Below the Limit of Quantification in PK Studies James R. Johnson source
presentation source		 9
PharmaSUG 2018 A CRO's perspective on successful partnering to deliver SDTM/SEND contributions Helen Owen,
Kirsty Payne		 source 7
PharmaSUG 2018 Coming soon: ADNCA and the PK submission Luke Reinbolt,
Liz MacDonald		 source 6
PharmaSUG 2018 Compare Pharmacokinetic Data Submission Processes in CDISC Environment Xiaopeng Li,
Shallabh Mehta,
Edward Elam		 source 7
PharmaSUG 2018 PK Data Explained Timothy J. Harrington source 9
PharmaSUG 2018 Preventing premature unblinding in PK/PD related studies Debbie Sisco,
Alice Zong		 source 11
PHUSE EU 2017 Visualizing Multiple Endpoints: Extending the Use of Forest Plots in Clinical Trials James R. Johnson,
Mark Jaros		 source
presentation source		 10
PharmaSUG CN 2017 Effective Statistical Programming Preparation and Support for CFDA Self-Inspections and Onsite Inspections Peng Wan 5
PharmaSUG 2017 CDISC Compliant NCA PK Parameter Analysis When Using Phoenix WinNonlin Renfang Hwang source 11
PharmaSUG 2017 RELREC - SDTM Programmer-s Bermuda Triangle Charumathy Sreeraman source 12
PHUSE EU 2016 Fast Track to Domain: SDTM.PC and SDTM.PP Lina Ulkjær Jørgensen source
presentation source		 2
SGF 2016 Fitting Multilevel Hierarchical Mixed Models Using PROC NLMIXED Raghavendra Kurada source 15
WUSS 2015 Exposure-Response Plots Using SAS Janette Garner source 8
PharmaSUG 2015 Programming Pharmacokinetic (PK) Timing and Dosing Variables in Oncology Studies: Demystified Kiran Cherukuri source 9
PHUSE EU 2014 Implementation of CDISC ADaM in the Pharmacokinetics Department Joanna Magielse,
Tineke Callant		 source
presentation source		 6
PHUSE EU 2014 Unuttered Questions of Statistical Programmers Aparajita Dey source
presentation source		 10
PharmaSUG CN 2014 Submission of Pharmacokinetics (PK) Data in a CDISC Compliant Format Yu Zhu 9
PHUSE EU 2013 eBESTreports - The Fastest Way to Conclusions [presentation] Tuomas Kemppainen,
Juha Hyssala		 source 25
PharmaSUG 2013 A Generic Concept to Handle SDTM (and other CDISC) Data Sets Peter Schaefer source 8
PHUSE EU 2012 A Peak at PK - An Introduction to Pharmacokinetics Hannah Twittchet,
Paul Grimsey		 source
presentation source		 9
PharmaSUG 2012 Considerations in the Submission of Pharmacokinetics (PK) Data in an SDTM-Compliant Format Fred Wood,
Peter Schaefer,
Richard Lewis		 source 8
MWSUG 2011 Outlier resistance of multivariate bioequivalence procedures Srinand P. Nandakumar,
Joseph W. McKean		 13
NESUG 2011 Geometric Statistics in PK Analysis - Programmeres Perspective Niraj J. Pandya,
Smitha Mullapudi		 4
PHUSE EU 2010 BeST - Bioequivalence Study Template Pekka Heikkilä source
presentation source		 9
PHUSE EU 2010 Clinetics Data Merge - A Platform for Exchange of Pharmacokinetic Data Ralf Schefer-Pregi,
Andreas Schwarzer		 source
presentation source		 5
PharmaSUG 2010 Using SAS Proc Power to Perform Model-based Power Analysis for Clinical Pharmacology Studies Peng Sun 11
PharmaSUG 2009 Fitting Compartmental Models to Multiple Dose Pharmacokinetic Data using SAS PROC NLMIXED Jing Su,
Peng Sun,
Xiaodong Li,
Alan H. Hartford		 9
PHUSE EU 2008 Exchange of Information for the Statistical Analysis and Reporting of PK Parameter Data Ann Cuijpers,
Sarah Rusch		 source 2
PHUSE EU 2007 Bootstrapping in a replicative bioequivalence study Feryal Tanriverdio,
Arne Ring		 source 11
PHUSE EU 2005 Harmonised PK Analysis & Reporting Ian Barretto source 1
MWSUG 2005 Using SAS To Assess Dose Proportionality In Dose Escalation Studies Keith Dunnigan 12
NESUG 2002 Integration of SAS and NONMEM for Automation of Population Pharmacokinetic/Pharmacodynamic Modeling on UNIX systems Alan Xiao,
Jill Fiedler-Kelly		 5
PharmaSUG 2000 A SAS Tool for the Presentation and Statistical Analysis of Data from Bioavailability and Bioequivalence Studies Melvin S. Munsaka,
Carl R. Haske		 8
PharmaSUG 2000 Constructing a Data Warehouse for Pharmacokinetic Data Stanley P. Koprowski Jr.,
Jeffrey S. Barrett,
Dwight J. Fowler		 9
SUGI 2000 Constructing a Data Warehouse for Pharmacokinetic Data Stanley P. Koprowski Jr.,
Dwight J. Fowler,
Jeffrey S. Barrett		 source 7
MWSUG 1999 Sample Size Determination From A Pilot Bioequivalence Study For A Future Pivotal Bioequivalence Study: A SAS Procedure Xiang Gao,
Henry Cheng		 7
MWSUG 1998 A Project Tracking and Analysis Application for Bioequivalence Trials A. David Mundt 4
NESUG 1996 BIOEQ4: Bioequivalence Macro to Create both Table and SAS data set according to the FDA Bioequivalence Guidelines Issued in 1992 Mary Kay McPherson 6
SEUGI 1995 A Way to Handle Pharmacokinetic Studies with SAS Software Jean-Michel Cardot source 8
SEUGI 1994 Model-Independent Pharmacokinetics Using SAS/PH-Kinetics Software Brian Fredric source 5
SEUGI 1991 Confidence Intervals for Bioequivalence Studies B. Jones,
D. J. Nichols,
P. Blood		 source 12
SUGI 1990 A SAS Macro Based System for the Preparation of Data for Comparative Bioavailability Analysis Kelly K. Antony,
Laurie T. Elstun		 source 5
SUGI 1989 The Application of Base SAS, SAS/STAT, and SAS/GRAPH Software to the Analysis and Presentation of Pharmacokinetic Data Philip H. Schwartz source 5
SUGI 1982 A Pharmacokinetic Analysis System (PAS) Raymond P. Chen,
Daniel M. Wildman		 source

Back to keywords